First Recurrence of Clostridium Difficile Infection: Clinical Relevance, Risk Factors, and Prognosis
Overview
Microbiology
Authors
Affiliations
Therapy for recurrent Clostridium difficile-associated diarrhea (CDAD) is challenging. We evaluated the frequency, associated risk factors, and prognosis of first CDAD recurrences. Prospective cohort study of all consecutive cases of primary CDAD diagnosed in a university hospital from January 2006 to June 2013. Recurrent infection was defined as reappearance of symptoms within 8 weeks of the primary diagnosis, provided that CDAD symptoms had previously resolved and a new toxin test was positive. Predictors of a first episode of recurrent CDAD were determined by logistic regression analysis. In total, 502 patients (51.6 % men) with a mean age of 62.3 years (SD 18.5) had CDAD; 379 (76 %) were cured, 61 (12 %) had a first recurrence, 52 (10 %) died within 30 days of the CDAD diagnosis, nine (2 %) required colectomy, and one was lost to follow-up. Among the 61 patients with a first recurrence, 36 (59.3 %) were cured, 15 (23.7 %) had a second recurrence, nine (15.3 %) died, and one (1.7 %) required colectomy. On multivariate analysis, age older than 65 years (OR 2.04; 95 % CI, 1.14-3.68; P < 0.02) and enteral nutrition (OR, 3.62; 95%CI, 1.66-7.87; P < 0.01) were predictors of a first recurrence. A risk score was developed for first CDAD recurrence using the predictive factors and selected biological variables. In our CDAD cohort, 12 % of patients had a first recurrence of this disease, in which the prognosis was less favorable than that of the primary episode, as it heralded a higher risk of additional recurrences. Patient age and enteral nutrition were predictors of a first recurrence.
Barbero Allende J, Urena I, Canivano L, Garcia S, Paz C, Olmo-Ruiloba A Rev Esp Quimioter. 2024; 38(1):48-54.
PMID: 39588562 PMC: 11758874. DOI: 10.37201/req/086.2024.
van Rossen T, van Beurden Y, Bogaards J, Budding A, Mulder C, Vandenbroucke-Grauls C BMC Infect Dis. 2024; 24(1):687.
PMID: 38987677 PMC: 11238444. DOI: 10.1186/s12879-024-09506-7.
Validation of clinical risk tools for recurrent infection.
Boone R, Lee E, Petri Jr W, Madden G Infect Control Hosp Epidemiol. 2024; :1-9.
PMID: 38721755 PMC: 11518676. DOI: 10.1017/ice.2024.75.
Microbiome profile and calprotectin levels as markers of risk of recurrent infection.
Vazquez-Cuesta S, Lozano Garcia N, Fernandez A, Olmedo M, Kestler M, Alcala L Front Cell Infect Microbiol. 2023; 13:1237500.
PMID: 37780848 PMC: 10534046. DOI: 10.3389/fcimb.2023.1237500.
San-Juan R, Origuen J, Campion K, Fernandez-Ruiz M, Diaz-Pollan B, Callejas-Diaz A BMJ Open. 2023; 13(9):e072121.
PMID: 37709311 PMC: 11148698. DOI: 10.1136/bmjopen-2023-072121.